{
    "organizations": [],
    "uuid": "4bef4722b044a1361d5ae1904fdef18c52b5d7e4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-obalon-announces-termination-of-pu/brief-obalon-announces-termination-of-public-offering-of-common-stock-idUSASB0C1X2",
    "ord_in_thread": 0,
    "title": "BRIEF-Obalon Announces Termination Of Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 23, 2018 / 2:31 PM / Updated 23 minutes ago BRIEF-Obalon Announces Termination Of Public Offering Of Common Stock Reuters Staff \nJan 23 (Reuters) - Obalon Therapeutics Inc: \n* OBALON ANNOUNCES TERMINATION OF PUBLIC OFFERING OF COMMON STOCK \n* OBALON THERAPEUTICS- TERMINATION OF UNDERWRITING AGREEMENT,CANCELLATION OF PREVIOUSLY ANNOUNCED OFFERING OF 5.5 MILLION SHARES AT PRICE OF $5.50/SHARE \n* OBALON - PURPORTED WHISTLEBLOWER CONTACTED CO‘S INDEPENDENT AUDITORS TO ALLEGE “IMPROPER REVENUE RECOGNITION” IN FISCAL Q4 \n* OBALON - ALLEGATIONS BY PURPORTED WHISTLEBLOWER WERE REPORTED TO CO LATE ON JAN. 22 \n* OBALON -‍CO‘S AUDIT COMMITTEE TO OVERSEE AN INTERNAL INVESTIGATION OF ALLEGATIONS RELATING TO ALLEGEDLY “IMPROPER REVENUE RECOGNITION” DURING Q4 2017 \n* OBALON - REPORTING ALLEGATIONS TO CO ON JAN. 22 MADE IT “INFEASIBLE” TO COMPLETE INVESTIGATION BEFORE INTENDED CLOSING OF PUBLIC OFFERING \n* OBALON - DOESN‘T CURRENTLY BELIEVE MATERIAL ADJUSTMENTS TO PRELIM, UNAUDITED REVENUE FOR Q4 2017, FY2017 REPORTED WILL BE REQUIRED DUE TO ALLEGATIONS Source text for Eikon: Further company coverage:",
    "published": "2018-01-23T16:31:00.000+02:00",
    "crawled": "2018-01-23T16:56:20.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "termination",
        "public",
        "offering",
        "common",
        "stock",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "obalon",
        "therapeutic",
        "inc",
        "obalon",
        "announces",
        "termination",
        "public",
        "offering",
        "common",
        "stock",
        "obalon",
        "termination",
        "underwriting",
        "agreement",
        "cancellation",
        "previously",
        "announced",
        "offering",
        "million",
        "share",
        "price",
        "obalon",
        "purported",
        "whistleblower",
        "contacted",
        "co",
        "independent",
        "auditor",
        "allege",
        "improper",
        "revenue",
        "recognition",
        "fiscal",
        "q4",
        "obalon",
        "allegation",
        "purported",
        "whistleblower",
        "reported",
        "co",
        "late",
        "obalon",
        "audit",
        "committee",
        "oversee",
        "internal",
        "investigation",
        "allegation",
        "relating",
        "allegedly",
        "improper",
        "revenue",
        "recognition",
        "q4",
        "obalon",
        "reporting",
        "allegation",
        "co",
        "made",
        "infeasible",
        "complete",
        "investigation",
        "intended",
        "closing",
        "public",
        "offering",
        "obalon",
        "currently",
        "believe",
        "material",
        "adjustment",
        "prelim",
        "unaudited",
        "revenue",
        "q4",
        "fy2017",
        "reported",
        "required",
        "due",
        "allegation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}